Stocks · Health care · Pharmaceutical Preparations

Regeneron Pharmaceuticals

REGN Clue Score51

United States Fiscal year ends December CIK 0000872589 Results filed 30 Oct 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$54.38M

$6.63M on a plan · $47.48M straight out of an exercise

Sold at will

$280.77K

1 of 127 sales

Net

−$54.38M

−$280.77K against sales at will